12.01.2013 Views

20 August 2002 - U.S. Patent and Trademark Office

20 August 2002 - U.S. Patent and Trademark Office

20 August 2002 - U.S. Patent and Trademark Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

TM 330 OFFICIAL GAZETTE AUGUST <strong>20</strong>, <strong>20</strong>02<br />

CLASS 5—(Continued).<br />

SN 78-055,410. GUSTAFSON, L.L.C., PLANO, TX. FILED 3-<br />

27-<strong>20</strong>01.<br />

RHIZOGARD<br />

FOR CLOTHIANIDIN APPLIED DIRECTLY ON<br />

CORN, CANOLA, SORGHUM, AND COTTON SEEDS<br />

TO CONTROL ROOTWORMS DISTRIBUTED BY INDE-<br />

PENDENT REPRESENTATIVES TO SEED-TREATMENT<br />

COMPANIES AND COMMERCIAL FARMERS IN THE<br />

AGRICULTURE INDUSTRY (U.S. CLS. 6, 18, 44, 46, 51<br />

AND 52).<br />

SN 78-056,655. PHARMACIA CORPORATION, PEAPACK,<br />

NJ. FILED 4-4-<strong>20</strong>01.<br />

CAPTOR<br />

FOR PHARMACEUTICAL PREPARATIONS, NAMELY<br />

PREPARATIONS FOR THE TREATMENT OF INFEC-<br />

TIOUS DISEASES, ONCOLOGICAL PREPARATIONS<br />

FOR THE TREATMENT OF CANCER, ANALGESICS,<br />

PHARMACEUTICAL PREPARATIONS FOR THE PRE-<br />

PARATIONS FOR THE TREATMENT AND SYMPTOMS<br />

OF DIABETES, PHARMACEUTICAL PREPARATIONS<br />

FOR THE TREATMENT OF OPTHALMOLOGICAL CON-<br />

DITIONS AND DISEASES, PHARMACEUTICAL PRE-<br />

PARATIONS FOR THE TREATMENT OF CENTRAL<br />

NERVOUS SYSTEMS DISEASES AND DISORDERS,<br />

PHARMACEUTICAL PREPARATIONS FOR THE<br />

TREATMENT OF PARKINSON’S DISEASE, GYNECO-<br />

LOGICAL PREPARATIONS FOR THE TREATMENT OF<br />

MENOPAUSAL DISORDERS, ANTI-INFLAMMATORY<br />

PHARMACEUTICAL PREPARATIONS, PHARMACEUTI-<br />

CAL PREPARATIONS FOR THE TREATMENT OF CAR-<br />

DIOVASCULAR DISEASES AND CONDITIONS,<br />

HORMONAL PREPARATIONS FOR THE TREATMENT<br />

OF HORMONE DEFICIENCIES, AND PHARMACEUTI-<br />

CAL PREPARATIONS FOR THE TREATMENT OF MI-<br />

GRAINES (U.S. CLS. 6, 18, 44, 46, 51 AND 52).<br />

SN 78-056,660. PHARMACIA CORPORATION, PEAPACK,<br />

NJ. FILED 4-4-<strong>20</strong>01.<br />

LAURELL<br />

FOR PHARMACEUTICAL PREPARATIONS, NAMELY<br />

PREPARATIONS FOR THE TREATMENT OF INFEC-<br />

TIOUS DISEASES, ONCOLOGICAL PREPARATIONS<br />

FOR THE TREATMENT OF CANCER, ANALGESICS,<br />

PHARMACEUTICAL PREPARATIONS FOR THE<br />

TREATMENT AND SYMPTOMS OF DIABETES, PHAR-<br />

MACEUTICAL PREPARATIONS FOR THE TREATMENT<br />

OF OPTHALMOLGICAL CONDITIONS AND DISEASES,<br />

PHARMACEUTICAL PREPARATIONS FOR THE<br />

TREATMENT OF CENTRAL NERVOUS SYSTEM DIS-<br />

EASES AND DISORDERS, PREPARATIONS FOR THE<br />

TREATMENT OF PARKINSON’S DISEASE, GYNECO-<br />

LOGICAL PREPARATIONS FOR THE TREATMENT OF<br />

MENOPAUSAL DISORDERS, ANTI-INFLAMMATORY<br />

PHARMACEUTICAL PREPARATIONS, PHARMACEUTI-<br />

CAL PREPARATIONS FOR THE TREATMENT OF CAR-<br />

DIOVASCULAR DISEASES AND CONDITIONS,<br />

HORMONAL PREPARATIONS FOR THE TREATMENT<br />

OF HORMONAL DEFICIENCIES AND PHARMACEUTI-<br />

CAL PREPARATIONS FOR THE TREATMENT OF MI-<br />

GRAINES (U.S. CLS. 6, 18, 44, 46, 51 AND 52).<br />

CLASS 5—(Continued).<br />

SN 78-056,661. PHARMACIA CORPORATION, PEAPACK,<br />

NJ. FILED 4-4-<strong>20</strong>01.<br />

PCAP<br />

FOR PHARMACEUTICAL PREPARATIONS, NAMELY<br />

PREPARATIONS FOR THE TREATMENT OF INFEC-<br />

TIOUS DISEASES, CANCER, DIABETES, OPHTHALMO-<br />

LOGIC CONDITIONS AND DISEASES, CENTRAL<br />

NERVOUS SYSTEM DISEASES AND DISORDERS, PAR-<br />

KINSON’S DISEASE, CARDIOVASCULAR DISEASES<br />

AND CONDITIONS, MIGRAINES, URINARY TRACT<br />

INFECTIONS AND URINARY BLADDER INFECTIONS,<br />

ANTI-INFLAMMATORY PHARMACEUTICAL PRE-<br />

PARATIONS, AND PHARMACEUTICAL PREPARA-<br />

TIONS FOR THE TREATMENT OF HORMONAL<br />

DISORDERS (U.S. CLS. 6, 18, 44, 46, 51 AND 52).<br />

SN 78-056,666. PHARMACIA CORPORATION, PEAPACK,<br />

NJ. FILED 4-4-<strong>20</strong>01.<br />

TIXXIT<br />

FOR PHARMACEUTICAL PREPARATIONS, NAMELY<br />

PREPARATIONS FOR THE TREATMENT OF INFEC-<br />

TIOUS DISEASES, CANCER, DIABETES, OPHTHALMO-<br />

LOGIC CONDITIONS AND DISEASES, CENTRAL<br />

NERVOUS SYSTEM DISEASES AND DISORDERS, PAR-<br />

KINSON’S DISEASE, CARDIOVASCULAR DISEASES<br />

AND CONDITIONS, MIGRAINES, URINARY TRACT<br />

INFECTIONS AND URINARY BLADDER INFECTIONS;<br />

ANTI-INFLAMMATORY PHARMACEUTICAL PRE-<br />

PARATIONS, AND PHARMACEUTICAL PREPARA-<br />

TIONS FOR THE TREATMENT OF HORMONAL<br />

DISORDERS (U.S. CLS. 6, 18, 44, 46, 51 AND 52).<br />

SN 78-057,612. SARAMAR, L.L.C., CHICAGO, IL. FILED 4-10-<br />

<strong>20</strong>01.<br />

CRYSTAL OCEAN WATERS<br />

FOR AIR FRESHENERS; ROOM DEODORIZERS (U.S.<br />

CLS. 6, 18, 44, 46, 51 AND 52).<br />

FIRST USE 8-13-<strong>20</strong>01; IN COMMERCE 8-13-<strong>20</strong>01.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!